Hallucinogenic drug interactions at human brain 5-HT2 receptors: implications for treating LSD-induced hallucinogenesis (Q34041519)

30 July 2017

Hallucinogenic drug interactions at human brain 5-HT2 receptors: implications for treating LSD-induced hallucinogenesis (English)

1 reference

lysergic acid diethylamide

30 July 2017

1 reference

B Sadzot

1

1 reference

30 July 2017

J M Baraban

2

1 reference

30 July 2017

R A Glennon

3

1 reference

30 July 2017

R A Lyon

4

1 reference

30 July 2017

S Leonhardt

5

1 reference

30 July 2017

C R Jan

6

1 reference

30 July 2017

M Titeler

7

1 reference

30 July 2017

1 January 1989

1 reference

30 July 2017

5

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

30 July 2017

98

1 reference

30 July 2017

495-499

1 reference

30 July 2017

4

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00441948

30 July 2017

0 references

cites work

Evidence for 5-HT2 involvement in the mechanism of action of hallucinogenic agents

1 reference

12 December 2020

Indolealkylamine analogs share 5-HT2 binding characteristics with phenylalkylamine hallucinogens

1 reference

12 December 2020

Antagonism of the effects of the hallucinogen DOM and the purported 5-HT agonist quipazine by 5-HT2 antagonists

1 reference

12 December 2020

A practical computer-based approach to the analysis of radioligand binding experiments

1 reference

12 December 2020

Effect of hallucinogens on spontaneous and sensory-evoked locus coeruleus unit activity in the rat: reversal by selective 5-HT2 antagonists.

1 reference

12 December 2020

Non-serotonergic [3H]ketanserin binding sites in striatal membranes are associated with a dopac release system on dopaminergic nerve endings

1 reference

12 December 2020

[3H]DOB: a specific agonist radioligand for 5-HT2 serotonin receptors.

1 reference

12 December 2020

Radioligand binding evidence implicates the brain 5-HT2 receptor as a site of action for LSD and phenylisopropylamine hallucinogens

1 reference

12 December 2020

3,4-Methylenedioxymethamphetamine (MDMA): stereoselective interactions at brain 5-HT1 and 5-HT2 receptors

1 reference

12 December 2020

5-HT1 and 5-HT2 binding properties of derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane (2,5-DMA).

1 reference

12 December 2020

Drug-induced discrimination: a description of the paradigm and a review of its specific application to the study of hallucinogenic agents

1 reference

12 December 2020

[125I]SCH 23982, a ‘selective’ D-1 receptor antagonist, labels with high affinity 5-HT1C sites in pig choroid plexus

1 reference

12 December 2020

Discriminative stimulus properties of MDA analogs

1 reference

12 December 2020

Properties of [3H]prazosin-labeled alpha 1-adrenergic receptors in rat brain and porcine neurointermediate lobe tissue.

1 reference

12 December 2020

3H-DOB (4-bromo-2,5-dimethoxyphenylisopropylamine) labels a guanyl nucleotide-sensitive state of cortical 5-HT2 receptors

1 reference

12 December 2020

[125I]-1-(2,5-dimethoxy-4-iodophenyl)-2-amino-propane: an iodinated radioligand that specifically labels the agonist high-affinity state of 5-HT2 serotonin receptors

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00441948

1 reference

Dimensions Publication ID

30 July 2017

0 references

1 reference